Will has 30 years’ experience in the international chemical and oil & gas industries, where he has held a variety of executive roles, focusing on the development and commercialisation of new technologies within large organisations and start-ups. Will has a degree in industrial chemistry, a PhD in polymer physics and MBA from University of Edinburgh Business School.
Xiongwei has been responsible for the development of both the NiTech® Crystallizer and the NiTech® Reactor. He is Professor of Chemical Engineering at Heriot Watt University, a Fellow of the Royal Society of Chemistry and of the Institution of Chemical Engineers, and has over 20 years experience in oscillatory baffled reactors. He recognised that real value would only be created by applying the science to industrial applications and thus initiated his work on continuous polymerisation.
Worked in manufacturing roles at senior levels with ICI, Zeneca, FMC and Flexsys before launching start-up company Oxford Catalysts (now named Velocys) in 2005, where he became COO and helped lead its successful IPO and later its acquisition of Velocys. He was Head of Technology and then Head of Manufacturing for the Technology Strategy Board between 2009-14. He is now Chairman of Oxford Biotrans, Amalyst, Added Scientific and Irish Manufacturing Research, a non-executive director of ZuvaSyntha and IfM Education & Consultancy Services, a Fellow of the Royal Society of Chemistry and a member of the Council of the Chemical Industries Association, and runs his own consultancy company, WillB Consulting Ltd.
Founder and chairman of International eChem and an adviser to Recycling Technologies. Previously, he worked for 17 years with ICI, and was an Executive Director of one of ICI’s major global businesses. Paul serves as a Global Expert with the World Economic Forum and is a Member of the Energy Institute and a Freeman of the City of London. He is a graduate of the University of York, and studied with the IMD business school in Switzerland.
Sandy is founding director and co-owner of Cogency Chemical Consultants, a specialist advisor to private equity and corporate clients on chemical sector mergers and acquisitions. He has over 30 years international experience in the chemical sector, including 25 years leading speciality chemical companies. He is Chairman of Marine Biopolymers and a former Chairman of Warwick International, Evolva SA, Chemical Sciences Scotland and non-executive director of Yule Catto plc (now Synthomer).
Andy has extensive experience in manufacturing within the chemical and process industries. Andy was a Site Manager for NOVA Innovene in the UK and France, and worked in a variety of technical and manufacturing roles for Shell Chemicals from 1986 – 1999. Andy is a Chemical Engineer, and a chartered member of the Institution of Chemical Engineers.
Christopher has had a career in telecommunications, technology, finance and law spanning more than 30 years, working in North and South America, Europe, the Middle East and Asia. In early 2017, he stepped down as a senior finance partner in the London Office of Latham & Watkins, a global law firm. Prior to that, he was an executive vice president of a pan-European data communications company with responsibilities including mergers and acquisitions, joint venture development, and capital markets issuances. Christopher serves on the boards of a number of companies in the technology sector, specialising in FinTech, EdTech and HRTech. Christopher is a solicitor of the Senior Courts of England and Wales and is a member of the New York Bar.
George’s experience in the chemical and pharmaceutical industries has ranged from agrochemicals through oral solid dose and topical drug formulation development. The key focus of much of his career has been in the development and sale of capex instrumentation into the pharmaceutical industry, as well as the successful sale of high-value drug development projects and licensing of drug delivery technologies within the CDMO industry. George graduated in chemistry at the University of Surrey.
